Leave a Legacy
Long term planning is vitally important for cancer research as it can often take decades to translate discoveries into new treatments. The prostate cancer drug abiraterone which was discovered and developed by us took decades of hard work before it was finally licensed for use in the UK. It’s because of the long term nature of our research that two of our most eminent scientists have decided to leave us a legacy in their Wills.
Professor Chris Marshall FRS, Director of Research explained his motivation:
"The ICR is one of the world’s most influential cancer research institutes and I am proud to have spent a large part of my career there. I want to ensure that the vital work continues at the Institute for as long as is necessary to defeat cancer, so I’ve decided to leave ICR a legacy in my Will. I hope you will consider doing the same.”
And former ICR Director Professor Robin Weiss shared those views adding “I have chosen not to specify where my legacy should be spent as I cannot foretell what the most pressing issues will be for the ICR at the time my legacy becomes available.”
But you don’t have to be a world-leading scientist to support our future work. By leaving a legacy in your Will, you could help us to train the next generation of world-leading scientists; you could help us further our understanding of the causes of cancer; and ultimately you could help us to make the discoveries that defeat cancer.
We know leaving a legacy to any organisation is a big decision and we have put together some frequently asked questions to help guide you through the process. In the FAQs you can find further information about different types of legacies, how to find a solicitor and recommended wording for your Will.
Alternatively you can contact the Legacy Team who will be happy to answer any questions you might have.
Last updated: 17 January 2014